Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Aldosterone and the heart: from basic research to clinical evidence.

Catena C, Colussi G, Marzano L, Sechi LA.

Horm Metab Res. 2012 Mar;44(3):181-7. doi: 10.1055/s-0031-1291318. Epub 2011 Nov 17. Review.

PMID:
22095099
[PubMed - indexed for MEDLINE]
2.

Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new.

Catena C, Colussi G, Brosolo G, Iogna-Prat L, Sechi LA.

Am J Cardiovasc Dis. 2012;2(1):50-7. Epub 2011 Dec 15.

PMID:
22254214
[PubMed]
Free PMC Article
3.

New perspectives on the role of aldosterone excess in cardiovascular disease.

Stowasser M.

Clin Exp Pharmacol Physiol. 2001 Oct;28(10):783-91. Review.

PMID:
11553016
[PubMed - indexed for MEDLINE]
4.

The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.

Funder JW.

Am J Cardiovasc Drugs. 2007;7(3):151-7. Review.

PMID:
17610342
[PubMed - indexed for MEDLINE]
5.

Mineralocorticoid antagonism and cardiac hypertrophy.

Nagata K.

Curr Hypertens Rep. 2008 Jun;10(3):216-21. Review.

PMID:
18765093
[PubMed - indexed for MEDLINE]
6.

Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.

Young MJ, Funder JW.

J Hypertens. 2002 Aug;20(8):1465-8. Review.

PMID:
12172301
[PubMed - indexed for MEDLINE]
7.

Aldosterone and cardiovascular disease.

Gaddam KK, Pimenta E, Husain S, Calhoun DA.

Curr Probl Cardiol. 2009 Feb;34(2):51-84. doi: 10.1016/j.cpcardiol.2008.10.002. Review.

PMID:
19135616
[PubMed - indexed for MEDLINE]
8.

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

Whaley-Connell A, Johnson MS, Sowers JR.

Prog Cardiovasc Dis. 2010 Mar-Apr;52(5):401-9. doi: 10.1016/j.pcad.2009.12.004. Review.

PMID:
20226958
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.

Young MJ.

Curr Opin Nephrol Hypertens. 2008 Mar;17(2):174-80. doi: 10.1097/MNH.0b013e3282f56854. Review.

PMID:
18277151
[PubMed - indexed for MEDLINE]
10.

Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.

Sechi LA, Colussi G, Di Fabio A, Catena C.

Am J Hypertens. 2010 Dec;23(12):1253-60. doi: 10.1038/ajh.2010.169. Epub 2010 Aug 12. Review.

PMID:
20706195
[PubMed - indexed for MEDLINE]
11.

The pharmacological treatment of primary aldosteronism.

Janmohamed S, Bouloux PM.

Expert Opin Pharmacother. 2006 Apr;7(5):563-73. Review.

PMID:
16553572
[PubMed - indexed for MEDLINE]
12.

Aldosterone, organ damage and dietary salt.

Catena C, Colussi G, Sechi LA.

Clin Exp Pharmacol Physiol. 2013 Dec;40(12):922-8. doi: 10.1111/1440-1681.12145. Review.

PMID:
23803228
[PubMed - indexed for MEDLINE]
13.

A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.

López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2372-82. doi: 10.1152/ajpheart.00283.2011. Epub 2011 Sep 16.

PMID:
21926338
[PubMed - indexed for MEDLINE]
Free Article
14.

Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet.

Wang Q, Clement S, Gabbiani G, Horisberger JD, Burnier M, Rossier BC, Hummler E.

Am J Physiol Renal Physiol. 2004 Jun;286(6):F1178-84. Epub 2004 Feb 3.

PMID:
14761862
[PubMed - indexed for MEDLINE]
Free Article
15.

Aldosterone-induced cardiac damage: focus on blood pressure independent effects.

Schmidt BM, Schmieder RE.

Am J Hypertens. 2003 Jan;16(1):80-6. Review.

PMID:
12517689
[PubMed - indexed for MEDLINE]
16.

[Profibrotic effects of aldosterone].

Van Den Meiracker AH, Huizenga AT, Boomsma F.

Ned Tijdschr Geneeskd. 2004 Jul 31;148(31):1532-6. Review. Dutch.

PMID:
15366722
[PubMed - indexed for MEDLINE]
17.

Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease.

Gomez-Sanchez EP.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):191-6. Review.

PMID:
15202613
[PubMed - indexed for MEDLINE]
18.

Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.

Catena C, Colussi G, Di Fabio A, Valeri M, Marzano L, Uzzau A, Sechi LA.

Horm Metab Res. 2010 Jun;42(6):440-5. doi: 10.1055/s-0029-1246185. Epub 2010 Jan 29. Review.

PMID:
20119883
[PubMed - indexed for MEDLINE]
19.

Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.

Funck RC, Wilke A, Rupp H, Brilla CG.

Adv Exp Med Biol. 1997;432:35-44. Review.

PMID:
9433509
[PubMed - indexed for MEDLINE]
20.

Aldosterone and the heart: still an unresolved issue?

Catena C, Colussi G, Nait F, Martinis F, Pezzutto F, Sechi LA.

Front Endocrinol (Lausanne). 2014 Oct 14;5:168. doi: 10.3389/fendo.2014.00168. eCollection 2014. Review.

PMID:
25352832
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk